InsidersTradesSigma
Across 2 buy signals with a settled T+90 return. Return basis: close on the day after publication.
Discover the detailed record of transactions filed by Scibetta James S, Director. Director active across 1 company, notably Matinas BioPharma Holdings, Inc.. In total, 2 disclosures have been logged. Activity tracked since 19 June 2021. The latest transaction was filed on 19 June 2021 (J). Regulator: SEC (Form 4). The full history is openly available.
2 of 2 declarations
Scibetta James S is a Board Member at Matinas BioPharma Holdings, Inc. He brings valuable experience in the biopharmaceutical sector, contributing to the strategic direction of the company. His role includes overseeing operations and commitment to best governance practices.